Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleINFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation

Richard W. Chapman, Michael Minnicozzi, Chander S. Celly, Jonathan E. Phillips, Ted T. Kung, R. William Hipkin, Xuedong Fan, Diane Rindgen, Gregory Deno, Richard Bond, Waldemar Gonsiorek, Motasim M. Billah, Jay S. Fine and John A. Hey
Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 486-493; DOI: https://doi.org/10.1124/jpet.106.119040
Richard W. Chapman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Minnicozzi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chander S. Celly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan E. Phillips
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ted T. Kung
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. William Hipkin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuedong Fan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane Rindgen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory Deno
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Bond
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Waldemar Gonsiorek
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Motasim M. Billah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jay S. Fine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John A. Hey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 322 no. 2 486-493
DOI 
https://doi.org/10.1124/jpet.106.119040
PubMed 
17496165

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received December 21, 2006
  • Accepted April 25, 2007
  • Published online July 19, 2007.

Article Versions

  • Earlier version (May 11, 2007 - 11:27).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Richard W. Chapman,
  2. Michael Minnicozzi,
  3. Chander S. Celly,
  4. Jonathan E. Phillips,
  5. Ted T. Kung,
  6. R. William Hipkin,
  7. Xuedong Fan,
  8. Diane Rindgen,
  9. Gregory Deno,
  10. Richard Bond,
  11. Waldemar Gonsiorek,
  12. Motasim M. Billah,
  13. Jay S. Fine and
  14. John A. Hey
  1. Departments of Pulmonary and Peripheral Neurobiology (R.W.C., M.M., C.S.C., J.E.P., T.T.K., M.M.B. J.A.H.), Inflammation (R.W.H., X.F., G.D., W.G., J.S.F.), Drug Metabolism and Pharmacokinetics (D.R.), and Tumor Biology (R.B.), Discovery Research, Schering-Plough Research Institute, Kenilworth, New Jersey
  1. Address correspondence to:
    Dr. Richard W. Chapman, Schering Plough Research Institute, Pulmonary and Peripheral Neurobiology, 2015 Galloping Hill Rd, K-15-1650, Kenilworth, NJ 07033. E-mail: richard.chapman{at}spcorp.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 2007 to April 2022

AbstractFullPdf
May 2007440153
Jun 2007180124
Jul 20077522140
Aug 2007534187
Sep 2007343456
Oct 2007353756
Nov 2007234544
Dec 2007242437
Jan 2008425269
Feb 2008423754
Mar 2008422969
Apr 2008453053
May 2008373145
Jun 2008283345
Jul 2008451736
Aug 2008454542
Sep 2008455450
Oct 2008634967
Nov 2008364338
Dec 2008234457
Jan 2009264663
Feb 2009293967
Mar 2009495670
Apr 2009343850
May 2009263645
Jun 2009283863
Jul 2009374762
Aug 2009253053
Sep 2009344554
Oct 2009403053
Nov 2009182850
Dec 200924940
Jan 2010392946
Feb 2010574261
Mar 2010443564
Apr 2010313135
May 2010393262
Jun 2010842838
Jul 2010162045
Aug 2010544246
Sep 2010504546
Oct 2010393635
Nov 2010305958
Dec 2010173344
Jan 2011242958
Feb 2011183245
Mar 2011303260
Apr 2011223159
May 2011244249
Jun 2011182936
Jul 2011312028
Aug 2011273143
Sep 2011442228
Oct 2011403854
Nov 2011372949
Dec 2011291536
Jan 2012452948
Feb 2012372445
Mar 2012393272
Apr 2012224142
May 2012323452
Jun 2012162031
Jul 2012492542
Aug 2012263036
Sep 2012232231
Oct 2012302728
Nov 2012292522
Dec 2012182423
Jan 2013132030
Feb 2013232125
Mar 2013302633
Apr 2013153041
May 2013181426
Jun 2013151219
Jul 2013182023
Aug 201381014
Sep 2013221626
Oct 2013162623
Nov 2013142418
Dec 2013161215
Jan 2014111010
Feb 2014172322
Mar 20141388
Apr 2014111013
May 2014202116
Jun 2014151230
Jul 2014192022
Aug 201491316
Sep 2014131415
Oct 2014201418
Nov 20141168
Dec 201415108
Jan 2015182714
Feb 201562124
Mar 2015141216
Apr 2015131213
May 2015181913
Jun 201520149
Jul 2015101712
Aug 2015221212
Sep 201513148
Oct 2015252625
Nov 2015151613
Dec 2015182317
Jan 2016352216
Feb 201628916
Mar 2016222025
Apr 2016171021
May 201626917
Jun 2016191014
Jul 2016252920
Aug 201612239
Sep 2016142013
Oct 2016142421
Nov 201641610
Dec 201653120
Jan 201733621
Feb 20174195
Mar 201723216
Apr 201752115
May 201722811
Jun 20171217
Jul 201703813
Aug 201734121
Sep 20178269
Oct 201763017
Nov 201774024
Dec 20175253
Jan 20183257
Feb 20186308
Mar 201842515
Apr 201833521
May 201822115
Jun 20183249
Jul 201814418
Aug 20183177
Sep 201812912
Oct 20186329
Nov 20184304
Dec 20182798
Jan 20193444
Feb 20192856
Mar 20191391
Apr 20193362
May 20192452
Jun 20191325
Jul 20191922
Aug 201934125
Sep 20193133
Oct 20191554
Nov 20192423
Dec 20193244
Jan 20201936
Feb 20201821
Mar 20201721
Apr 20204961
May 20201195
Jun 20202443
Jul 20201132
Aug 20203026
Sep 20201813
Oct 20203163
Nov 2020241311
Dec 20202482
Jan 20214795
Feb 20212688
Mar 20214887
Apr 202130114
May 20214164
Jun 20213262
Jul 20212564
Aug 20214994
Sep 20212676
Oct 20212263
Nov 20213593
Dec 20214032
Jan 20222647
Feb 20222934
Mar 202223103
Apr 20226168

Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 381 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 381, Issue 2
1 May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleINFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation

Richard W. Chapman, Michael Minnicozzi, Chander S. Celly, Jonathan E. Phillips, Ted T. Kung, R. William Hipkin, Xuedong Fan, Diane Rindgen, Gregory Deno, Richard Bond, Waldemar Gonsiorek, Motasim M. Billah, Jay S. Fine and John A. Hey
Journal of Pharmacology and Experimental Therapeutics August 1, 2007, 322 (2) 486-493; DOI: https://doi.org/10.1124/jpet.106.119040

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleINFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation

Richard W. Chapman, Michael Minnicozzi, Chander S. Celly, Jonathan E. Phillips, Ted T. Kung, R. William Hipkin, Xuedong Fan, Diane Rindgen, Gregory Deno, Richard Bond, Waldemar Gonsiorek, Motasim M. Billah, Jay S. Fine and John A. Hey
Journal of Pharmacology and Experimental Therapeutics August 1, 2007, 322 (2) 486-493; DOI: https://doi.org/10.1124/jpet.106.119040
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PK/PD of PDE Inhibitors in Autoimmune Hepatitis
  • Immunopharmacologic Assessment of KPL-404, a CD40 Antagonist
  • RCTR1 Promotes Alveolar Fluid Clearance
Show more Inflammation, Immunopharmacology, and Asthma

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics